Nastech to Host Webinar on its RNAi Therapeutics Programs and siRNA Delivery Technology
Complete the form below to unlock access to ALL audio articles.
Nastech Pharmaceutical Company Inc. has announced that it will host a Webinar concerning its emerging siRNA therapeutics programs and siRNA drug delivery technology. Steven C. Quay, M.D., Ph.D., Chairman, President and CEO will present at the event.
What: RNAi webinar on the science and business of RNAi therapeutics followed by a Q&A session. Questions may be emailed in advance to rnaiwebinar@nastech.com or during the event through the webinar interface
When: Thursday, November 9, 2006, from 10:30-11:15 AM U.S. East Coast time
How: Live over the Internet FREE via a simple advanced registration online.
Where: Webinar will be available online. once you are registered
If you are unable to participate during the live RNAi webinar webcast, an archive and replay will be available for 30 days via Nastech's website.
During the webinar, Dr. Quay will provide an overview of the exciting science behind RNAi and discuss the Company's rheumatoid arthritis and influence therapeutics programs as well as the Company's molecular biology based drug delivery technology.
